Enforcement Escalation
The U.S. Food and Drug Administration has significantly ramped up enforcement against unauthorized disposable vape products in 2026. A new round of warning letters issued in May targets several major importers and distributors, signaling a shift toward more aggressive market action.
According to agency data, the number of warning letters issued to vaping product manufacturers and retailers in Q1 and Q2 of 2026 has already exceeded the total for all of 2025. The FDA is also increasing the use of import detention orders, which physically stop products at ports of entry before they reach the domestic market.
“The message is clear: products that do not have a marketing authorization order from the FDA are marketed unlawfully and will face enforcement action.”
Impact on the Market
The crackdown has created uncertainty across the disposable vape supply chain. Several brands have paused new product launches pending review of their Premarket Tobacco Product Applications (PMTAs).
Industry analysts note that the enforcement wave is disproportionately affecting smaller brands, while larger manufacturers with established regulatory teams are better positioned to navigate the process. The estimated cost of a complete PMTA submission can exceed $500,000, creating a significant barrier to entry.
What This Means for Retailers
Vape shop owners and online retailers should review their current inventory for unauthorized products. The FDA has indicated it will pursue enforcement against retailers as well as manufacturers. Key steps include verifying that each product either has a marketing authorization order or a pending PMTA filed before the applicable deadline.